FLUCOV-IDX Trademark

Trademark Overview


On Thursday, November 12, 2020, a trademark application was filed for FLUCOV-IDX with the United States Patent and Trademark Office. The USPTO has given the FLUCOV-IDX trademark a serial number of 90315487. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, December 22, 2023. This trademark is owned by Ipsum Diagnostics LLC. The FLUCOV-IDX trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 (COVID-19) and influenza; Diagnostic preparations for medical purposes, namely, for diagnosing SARS-CoV-2 (COVID-19) and influenza

Medical analysis services for diagnostic and treatment purposes of SARS-CoV-2 (COVID-19) and influenza provided by medical laboratories; Medical diagnostic testing, monitoring and reporting services for SARS-CoV-2 (COVID-19) and influenza; Medical testing for diagnostic or treatment purposes in the field of SARS-CoV-2 (COVID-19) and influenza
flucov-idx

General Information


Serial Number90315487
Word MarkFLUCOV-IDX
Filing DateThursday, November 12, 2020
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateFriday, December 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 (COVID-19) and influenza; Diagnostic preparations for medical purposes, namely, for diagnosing SARS-CoV-2 (COVID-19) and influenza
Goods and ServicesMedical analysis services for diagnostic and treatment purposes of SARS-CoV-2 (COVID-19) and influenza provided by medical laboratories; Medical diagnostic testing, monitoring and reporting services for SARS-CoV-2 (COVID-19) and influenza; Medical testing for diagnostic or treatment purposes in the field of SARS-CoV-2 (COVID-19) and influenza

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIpsum Diagnostics LLC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30350

Trademark Events


Event DateEvent Description
Friday, December 22, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 14, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 2, 2022ASSIGNED TO EXAMINER
Tuesday, October 4, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 6, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 7, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 7, 2021LETTER OF SUSPENSION E-MAILED
Thursday, October 7, 2021SUSPENSION LETTER WRITTEN
Wednesday, October 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 12, 2021NON-FINAL ACTION E-MAILED
Monday, April 12, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 7, 2021ASSIGNED TO EXAMINER
Tuesday, January 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 16, 2020NEW APPLICATION ENTERED